Healthcare / Medical Care FacilitiesBSE
$492.55
-11.70 (-1.87%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 20%
FCF escenarios
weak_data · normalized FCF $421.7M · quality 48.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
49/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$61.2B
P/E
28.8x
↑EV/EBITDA
17.5x
↑ROE
47.5%
↑Gross Margin
88.6%
↑Debt/Equity
0.27
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+57.8%
FCF CAGR
—
FCF margin
27.4%
FCF / Net income
0.99x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $8.01B · net income $2.22B · FCF $2.19B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $8.01B | $8.01B | $4.69B | $3.24B | $2.04B |
| Net Income | $2.22B | $2.22B | $799.4M | $692.1M | $337.4M |
| EBITDA | $3.58B | $3.58B | $1.47B | $990.9M | $482.0M |
| EPS | 17.81 | 17.81 | 6.42 | 5.57 | 2.74 |
| Gross Margin | 88.6% | 88.6% | 88.4% | 90.4% | 89.3% |
| Operating Margin | 37.7% | 37.7% | 23.8% | 27.1% | 22.7% |
| Net Margin | 27.7% | 27.7% | 17.0% | 21.3% | 16.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.27 | 0.27 | 0.04 | 0.00 | 0.01 |
| Cash Flow | |||||
| Free Cash Flow | $2.19B | $2.19B | $421.7M | $211.5M | $-210.3M |
| Returns | |||||
| ROE | 47.5% | 47.5% | 29.3% | 36.0% | 26.8% |
| Valuation | |||||
| P/E | 28.82 | 28.82 | — | — | — |
| EV/EBITDA | 17.45 | 17.45 | — | — | — |
| P/B | 13.14 | 13.14 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 70.8% | 70.8% | 44.6% | 59.1% | — |
| EPS Growth | 177.4% | 177.4% | 15.3% | 103.4% | — |
| Dividend Yield | 0.2% | 0.2% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
34.9%
EPS terminal req.
$43.71
Spread vs growth
142.5%
5Y implied EPS CAGR
24.3%
EPS terminal req.
$52.88
Spread vs growth
153.1%
10Y implied EPS CAGR
16.9%
EPS terminal req.
$85.17
Spread vs growth
160.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-14.0%
Start / end P/E
111.6x → 34.5x
EPS bridge
6.42 → 17.81
Residual
-122.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.